Armata Pharmaceuticals (ARMP) Cash from Operations (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.37% |
| Dec 31, 2025 | -55.28% |
| Sep 30, 2025 | 40.40% |
| Jun 30, 2025 | 4.87% |
| Mar 31, 2025 | 4.38% |
| Dec 31, 2024 | 10.56% |
| Sep 30, 2024 | 12.91% |
| Jun 30, 2024 | 3.85% |
| Mar 31, 2024 | -30.57% |
| Dec 31, 2023 | 16.32% |
| Sep 30, 2023 | 19.68% |
| Jun 30, 2023 | 31.36% |
| Mar 31, 2023 | -67.57% |
| Dec 31, 2022 | -1.47% |
| Sep 30, 2022 | -26.82% |
| Jun 30, 2022 | -131.81% |
| Mar 31, 2022 | 59.12% |
| Dec 31, 2021 | -73.21% |
| Sep 30, 2021 | -9.39% |
| Jun 30, 2021 | 17.11% |
| Mar 31, 2021 | 13.12% |
| Dec 31, 2020 | -62.42% |
| Sep 30, 2020 | -0.62% |
| Jun 30, 2020 | 8.88% |
| Mar 31, 2020 | -55.08% |
| Dec 31, 2019 | 40.25% |
| Sep 30, 2019 | 21.62% |
| Jun 30, 2019 | -136.97% |
| Mar 31, 2019 | 23.04% |
| Dec 31, 2018 | -58.17% |
| Sep 30, 2018 | -7.68% |
| Jun 30, 2018 | 46.95% |
| Mar 31, 2018 | -49.26% |
| Dec 31, 2017 | -299.49% |
| Sep 30, 2017 | 79.77% |
| Jun 30, 2017 | 11.15% |
| Mar 31, 2017 | -120.23% |
| Dec 31, 2016 | 52.16% |
| Sep 30, 2016 | -8.26% |
| Jun 30, 2016 | 6.26% |